Clinical study of astaxanthin on glucose metabolism and vascular functio
Not Applicable
- Conditions
- healthy volunteers including prediabetes
- Registration Number
- JPRN-UMIN000045518
- Lead Sponsor
- Kamiichi General Hospital
- Brief Summary
After ASTX (12mg/day) supplementation for 12 weeks, the glucose level at 30 min by 75g OGTT was significantly decreased compared to before. The level of HbA1c was also significantly decreased compared to before.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 53
Inclusion Criteria
Not provided
Exclusion Criteria
1) Those who have been diagnosed with diabetes or who have been diagnosed with diabetes. 2) Women who are pregnant or may be pregnant, women who wish to become pregnant, and Lactating woman. 3) Those who are receiving drug therapy at a medical institution. 4) In addition, those who are judged to be inappropriate for this study by the clinical research investigator or the co-investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c
- Secondary Outcome Measures
Name Time Method 75g OGTT,RHI,Lipids